Mystic Pharmaceuticals Appoints Gerald D. Cagle Ph.D. And Grady Rylander M.D. To Scientific Advisory Board

Mystic Pharmaceuticals, Inc., a privately held integrated specialty pharmaceutical company, announced today that Gerald D. Cagle Ph.D. and Grady Rylander M.D. have joined Mystic's Scientific Advisory Board. Dr. Cagle is the former Chief Scientific Officer and Senior Vice President of Research and Development of Alcon Laboratories, Inc. Dr. Rylander is a board certified ophthalmologist with the Eye Institute of Austin and a Professor in Biomedical Engineering at the University of Texas-Austin. 

Suggested Articles

EQRx is adding a pair of PD-1/PD-L1 meds to its pipeline through a deal with CStone worth $150 million upfront but could net the latter $1.15 billion.

All eyes are on Pfizer’s COVID-19 vaccine work, but the Big Pharma has today quietly culled two midstage trials and one phase 1 test.

All subjects had lower extremity weakness after receiving antisense oligonucleotide GTX-102, leading Ultragenyx to pause the study.